Navigation Links
Study Helps Medical Education Leaders Navigate the New Regulatory and Financial Landscape
Date:8/8/2014

CHAPEL HILL, N.C., Aug. 8, 2014 /PRNewswire/ -- Medical education leaders in the medical device and pharmaceutical sectors are finding it challenging to navigate the current regulatory and financial landscape.

These challenges - one affecting program content and delivery and the other affecting resources - have made it even more important for medical education groups to effectively reach physicians and to efficiently use their resources.

To help medical education leaders succeed in this environment, research and consulting firm Best Practices, LLC conducted a study that pinpoints how organizations are developing and delivering education programs and which presenters and venues have the highest impact for physicians. In addition, the study reviews how companies are allocating their education budgets and developing performance measures to demonstrate their group's effectiveness.

The study, "Professional Medical Education Excellence: Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace," provides segments for both pharmaceutical and medical device companies.

One of the study's findings was that a majority of organizations in both the device and pharma segments expect their multi-disciplinary programs to increase in the next 2-3 years. With healthcare reform putting a greater emphasis on health outcomes, some education leaders believe the emphasis on coordination of care inherent in multi-disciplinary programs is behind the expected growth.

Other benchmarks and insights in the study include:

  • The funding channels utilized by medical education groups
  • The effectiveness of different medical education program types and delivery channels
  • The use of multi-disciplinary medical education programs
  • Future trends in medical education programs and technology

The study also informs education leaders on education trends in emerging markets.

The research project includes observations and insights from 32 leaders with 31 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 14 medical device firms and 18 leaders from 17 biopharmaceutical companies.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1305.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma
2. For Second Year in a Row, RIVA Named Top IV Robot in Study Ranking Pharmacy Automation
3. KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
4. Kaiser Permanente Study Finds Shingles Vaccine Remains Effective After Chemotherapy
5. Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce First Patient Dosed in Phase II Study of VPD-737 in Prurigo Nodularis
6. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
7. New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
8. EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
9. Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers
10. Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children
11. Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , Jan 20, 2017 Research and ... Testing Market Trends, Opportunities, and Future" report to their offering. ... This research ... emerging trends, and technologies, and provides a snapshot of the key ... 2015 and forecasts are provided from 2016 to 2020. The market ...
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product ... as Chief Medical Officer. Dr Weinberg will be based in ... ... than 17 years as a pharmaceutical and biotech executive with experience ... course of his career, he has interfaced with the US Food ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements ... deals and agreements entered into by the world,s leading ... Top deals by value - Deals listed by company ... The report provides understanding and access to the partnering ... healthcare companies. The report provides an analysis of ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... , ... Seamild, the largest manufacturer of oats in China, is now aiming ... As Oat is recognized globally as one of the healthiest cereals, XieQingkui, the founder ... is a move to sow the seed of good karma. Buddhism spirit featuring benevolence ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home ... and community. “Coming Home 2017” will be held on Friday January 27 ...
(Date:1/21/2017)... Santa Rosa, CA (PRWEB) , ... January 21, ... ... announce the opening of its new medical office in Petaluma, located at 167 ... full-service casting room, access to SRO sports medicine and rehabilitation services ...
(Date:1/21/2017)... ... January 21, 2017 , ... The ... Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety ...
(Date:1/20/2017)... ... , ... A new partnership between Goodwill® and Roadie, Inc. aims to make ... clothes to couches to dressers and bicycles. Roadie — the national on-the-way delivery network ... donation center through February 28th. , “January is an exciting time when resolutions ...
Breaking Medicine News(10 mins):